Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy

TH Ho, D Bundman, DL Armstrong… - Human molecular …, 2005 - academic.oup.com
TH Ho, D Bundman, DL Armstrong, TA Cooper
Human molecular genetics, 2005academic.oup.com
Myotonic dystrophy type I (DM1) is an RNA-mediated disease caused by a non-coding CTG
repeat expansion. A key feature of the RNA-mediated pathogenesis model for DM is the
disrupted splicing of specific pre-mRNA targets. A link has been established between
splicing regulation by CUG-BP1, a member of the CELF family of proteins, and DM1
pathogenesis. To determine whether increased CUG-BP1 function was sufficient to model
DM, transgenic mice overexpressing CUG-BP1 (MCKCUG-BP1) in heart and skeletal …
Abstract
Myotonic dystrophy type I (DM1) is an RNA-mediated disease caused by a non-coding CTG repeat expansion. A key feature of the RNA-mediated pathogenesis model for DM is the disrupted splicing of specific pre-mRNA targets. A link has been established between splicing regulation by CUG-BP1, a member of the CELF family of proteins, and DM1 pathogenesis. To determine whether increased CUG-BP1 function was sufficient to model DM, transgenic mice overexpressing CUG-BP1 (MCKCUG-BP1) in heart and skeletal muscle, two tissues affected in DM1, were generated. Histological and electron microscopic analyses of skeletal muscle reveal common pathological features with DM tissues: chains of central nuclei, degenerating fibers and centralized NADH reactivity. MCKCUG-BP1 mice have disrupted splicing of three CELF target pre-mRNAs, cardiac troponin T (Tnnt2), myotubularin-related 1 gene (Mtmr1) and the muscle-specific chloride channel (Clcn1), consistent with that observed in DM heart and skeletal muscle. The results are consistent with a mechanism for DM pathogenesis in which expanded repeats result in increased CUG-BP1 activity and/or other CELF family members and have trans-dominant effects on specific pre-mRNA targets.
Oxford University Press